Kennedy US health secretary hearings: a low-key future for nicotine alternatives?

The first fiery hearing for the confirmation of Robert F Kennedy Jr. as US secretary of health and human services went on with plenty of fireworks but little of substance for the nicotine alternatives industry.

The hearing before the Senate’s Finance Committee largely revolved around Kennedy’s positions on the hot-button issues of the day: vaccines, women’s reproductive rights and government spending – in this case in the form of federal health programmes Medicare and Medicaid.

Read full article
I'm already a subscriber

Freddie Dawson

Senior news editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the TobaccoIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation